Recombinant human interferon α1b

DRUG2 trials

Sponsors

Xijing Hospital

Conditions

Melanoma

Early Phase 1

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Not yet recruitingNCT06212388

Xijing HospitalMelanoma

Start: 2024-01-24End: 2028-10-30Target: 10Updated: 2024-01-25

Phase 1

Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma

Not yet recruitingNCT05539118

Xijing HospitalMelanoma

Start: 2022-09-30End: 2026-12-31Target: 48Updated: 2022-09-14